<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04949152</url>
  </required_header>
  <id_info>
    <org_study_id>41618915.1.0000.5404</org_study_id>
    <nct_id>NCT04949152</nct_id>
  </id_info>
  <brief_title>Brazilian Diabetes Study: a Type 2 Diabetes Prospective Cohort</brief_title>
  <acronym>BDS</acronym>
  <official_title>Brazilian Diabetes Study: a Type 2 Diabetes Prospective Cohort</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Campinas, Brazil</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Campinas, Brazil</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ongoing prospective cohort of type 2 diabetes individuals.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study population included individuals with type 2 diabetes aged between 40 and 70 years&#xD;
      old, living in the metropolitan area of Campinas, Brazil. The volunteers were recruited&#xD;
      between 2016 and 2020 through radio, newspaper, television and social media advertisements. A&#xD;
      total of 1046 participants were enrolled into the study so far.&#xD;
&#xD;
      All participants were firstly invited to an interview with the physician-researcher for&#xD;
      medical story register and physical examination. Afterwards, all participants were submitted&#xD;
      to the following procedures: blood and urine samples collection, dual-energy X-ray&#xD;
      absorptiometry, 6 minutes walk test, hand strength test, bone densitometry test, diabetic&#xD;
      polyneuropathy evaluation, advanced glycation end-product measurement, electrocardiogram,&#xD;
      echocardiogram, carotid doppler ultrasound, flow-mediated dilation, diabetic retinopathy&#xD;
      assessment, ambulatory blood pressure monitoring and cardiac computed tomography for calcium&#xD;
      scoring. After full examination, patients were contacted every year for 5 years for endpoints&#xD;
      registration. The primary endpoint was a composite of all-cause mortality, myocardial&#xD;
      infarction, stroke and myocardial revascularization. Secondary endpoints were end-stage&#xD;
      kidney disease requiring dialysis and limb amputation. Study data were collected and managed&#xD;
      using REDCap electronic data capture tools.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Anticipated">May 31, 2026</completion_date>
  <primary_completion_date type="Actual">May 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>5 years</time_frame>
    <description>All cause death, myocardial infarction, stroke, myocardial revascularization</description>
  </primary_outcome>
  <enrollment type="Anticipated">1046</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <condition>Diabete Mellitus</condition>
  <condition>Coronary Artery Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals from both genders, aged 40 to 70 years-old, with confirmed diagnosis of type 2&#xD;
        diabetes mellitus.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Diagnosed type 2 diabetes&#xD;
&#xD;
          -  Age between 40 and 70 years old&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unconfirmed diagnosis of diabetes&#xD;
&#xD;
          -  Intellectual disability&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Clinical research center</name>
      <address>
        <city>Campinas</city>
        <state>Sp</state>
        <zip>13083887</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>joaquim barreto, MD</last_name>
      <phone>+55 19 3521 7959</phone>
      <email>joaquimbarretoantunes@gmail.com</email>
    </contact>
    <investigator>
      <last_name>joaquim barreto, md</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>andrei c sposito, md, phd</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>vaneza lira wolf, msc</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>ikaro breder, md</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>luiz sergio f carvalho, md, phd</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 25, 2021</study_first_submitted>
  <study_first_submitted_qc>June 25, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 2, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Campinas, Brazil</investigator_affiliation>
    <investigator_full_name>Andrei Carvalho Sposito</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>cardiovascular disease</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

